91 related articles for article (PubMed ID: 2176518)
1. Effect of erythropoietin on parameters of sympathetic nervous activity in patients undergoing chronic haemodialysis.
Fritschka E; Neumayer HH; Seddighi S; Thiede HM; Distler A; Philipp T
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):135S-138S. PubMed ID: 2176518
[TBL] [Abstract][Full Text] [Related]
2. [Effect of erythropoietin therapy on alpha receptor density in chronic dialysis patients].
Fritschka E; Neumayer HH; Seddighi S; Distler A; Philipp T
Med Klin (Munich); 1991 Jul; 86(7):353-9. PubMed ID: 1656181
[TBL] [Abstract][Full Text] [Related]
3. Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration during treatment of renal anemia with recombinant human erythropoietin.
Schiffl H
Int J Artif Organs; 1992 Jun; 15(6):343-8. PubMed ID: 1639525
[TBL] [Abstract][Full Text] [Related]
4. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
5. [The effect of recombinant human erythropoietin (rHu-EPO) on the autonomic nervous system in patients hemodialyzed for chronic kidney failure].
Pacyk G; Grzeszczak W
Pol Arch Med Wewn; 1997 Jan; 97(1):22-9. PubMed ID: 9235548
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study.
Albertazzi A; Di Liberato L; Daniele F; Battistel V; Colombi L
Int J Artif Organs; 1998 Jan; 21(1):12-8. PubMed ID: 9554820
[TBL] [Abstract][Full Text] [Related]
7. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
[TBL] [Abstract][Full Text] [Related]
8. Decreased number of alpha-adrenergic receptors in platelets of patients on maintenance haemodialysis.
Brodde OE; Daul A; Graben N
Proc Eur Dial Transplant Assoc; 1983; 19():270-4. PubMed ID: 6308599
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
10. [Influence of long-term treatment with human recombinant erythropoietin on secretion of hormones regulating carbohydrate metabolism in hemodialyzed patients with chronic uremia].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Pol Arch Med Wewn; 1995 Dec; 94(6):488-94. PubMed ID: 8618811
[TBL] [Abstract][Full Text] [Related]
11. [Effect of recombinant human erythropoietin (rHu-EPO) on anemia and selected biochemical parameters in patients in the pre-dialysis period].
Sułowicz W; Drozdz M; Hanicki Z; Kraśniak A; Kuźniewski M
Przegl Lek; 1992; 49(1-2):50-3. PubMed ID: 1455007
[TBL] [Abstract][Full Text] [Related]
12. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
Bartůnková J; Sulková S; Cebecauer M
Cas Lek Cesk; 1995 Dec; 134(23):756-9. PubMed ID: 8599817
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
14. [Anemia management in haemodialysis. EuCliD database in Spain].
Avilés B; Coronel F; Pérez-García R; Marcelli D; Orlandini G; Ayala JA; Rentero R
Nefrologia; 2002; 22(6):555-63. PubMed ID: 12516289
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of clinical parameters of chronically hemodialyzed patients not requiring treatment with erythropoietin and patients treated with erythropoietin].
Majdan M; Ksiazek A; Swatowski A; Sokołowska G; Bartler I
Pol Arch Med Wewn; 1994 Jun; 91(6):461-6. PubMed ID: 7971467
[TBL] [Abstract][Full Text] [Related]
16. Autonomic neuropathy in hemodialysis patients treated with recombinant human erythropoietin.
Stojcheva-Taneva OO; Polenakovic MH
Int J Artif Organs; 1996 Oct; 19(10):574-7. PubMed ID: 8946232
[TBL] [Abstract][Full Text] [Related]
17. [Sympathetic activity in terminal renal failure and kidney transplants].
Lang R; Michels J; Becker-Berke R; Lukowski K; Vlaho V; Grundmann R
Klin Wochenschr; 1984 Nov; 62(21):1025-31. PubMed ID: 6392724
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
[TBL] [Abstract][Full Text] [Related]
20. Arterial hypotension in chronic hemodialyzed patients.
Daul AE; Wang XL; Michel MC; Brodde OE
Kidney Int; 1987 Nov; 32(5):728-35. PubMed ID: 2828750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
